Image

Outpatient Laparoscopic Radical Prostatectomy

Recruiting
18 years of age
Male
Phase N/A

Powered by AI

Overview

The purpose of the study is to evaluate the incidence of surgery-related complications between Day 0 and Day 30.

Description

This is an observational, prospective, open, non-comparative (single arm), bicentric study.

This study is aimed at patients with prostate cancer for whom an ambulatory laparoscopic radical prostatectomy has been validated at a multidisciplinary consultation meeting. The possibility of performing this procedure on an outpatient basis is left to the surgeon's discretion, according to well-defined medical procedure criteria.

This cohort is part of the usual care. The study will observe the incidence and describe the type, number, severity, duration and frequency of procedure-related complications that may arise in the first month post-op of ambulatory Laparoscopic Radical Prostatectomy. For this reason, patient follow-up will stop at 1 month after surgery, during a routine follow-up visit.

Eligibility

Inclusion Criteria:

  • Male, age ≥ 18 years;
  • Localized prostate cancer;
  • Validation in a multidisciplinary consultation meeting of curative treatment;
  • Scheduled laparoscopic radical prostatectomy;
  • Patient able to understand the information related to the study, to read the information leaflet and to signify his/her non-opposition or opposition to participating in the study;
  • Membership of a social security scheme;
  • Patient having been informed and having given oral non-opposition.

Exclusion Criteria:

  • Surgical emergency;
  • Patient not eligible for ambulatory care;
  • Long-term curative anti-coagulant treatment;
  • Resident more than 100km from the clinic;
  • Home alone the first night;
  • Patient under guardianship, curatorship or deprivation of liberty.

Study details

Prostate Cancer

NCT05975775

GCS Ramsay Santé pour l'Enseignement et la Recherche

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.